FDA commissioner's contingency fund draws Rep. Barton's attention in Aug. 21 letter to Kessler.
Executive Summary
FDA COMMISSIONER "CONTINGENCY FUND" DRAWS REP. BARTON INQUIRY in an Aug. 21 letter to Commissioner Kessler. Barton's (R-Tex.) House Commerce/Oversight & Investigations Subcommittee has "received information that you as [FDA] commissioner have a contingency fund under which you have reportedly used funds at your discretion to fund activities not heretofore disclosed to the Congress," the letter states.